Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPEF.L Regulatory News (APEF)

  • There is currently no data for APEF

EPT Disclosure

22 Jul 2009 12:01

RNS Number : 0930W
Cazenove
22 July 2009
 



DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

1. KEY INFORMATION

Name of exempt principal trader

Cazenove

Company dealt in

Bramdean Alternatives Limited

Class of relevant security to which the dealings being disclosed relate (Note 1)

No par value 

Date of dealing

21st July 2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

39,762 0.04

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

39,762 0.04

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

Class of relevant security: 

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Rights to subscribe (Note 2)

Class of relevant security:

Details

3. DEALINGS (Note 3)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 4)

Purchases

Sales

20,000

0.50

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 5)

Number of securities (Note 6)

Price per unit (Note 4)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 6)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 4) 

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 4)

(d) Other dealings (including new securities) (Note 3)

Nature of transaction (Note 7)

Details

Price per unit (if applicable) (Note 4)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 38.5(b) attached? (Note 8) NO

Date of disclosure

22nd July 2009

Contact name

Jeffrey Dalton-Brown

Telephone number

0207 155 5017

Name of offeree/offeror with which connected

Bramdean Alternatives Limited

Nature of connection (Note 9)

Cazenove are broker to Bramdean Alternatives Limited

Notes

The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMCKBKKDBKDDOB
Date   Source Headline
15th Sep 20172:00 pmRNSResult of AGM
1st Sep 20173:54 pmRNSPortfolio Listing, July 2017
30th Aug 20171:24 pmRNSNet Asset Value, July 2017
27th Jul 20174:29 pmRNSPortfolio Listing, June 2017
26th Jul 201711:56 amRNSNet Asset Value, June 2017
12th Jul 20177:00 amRNSPosting of Annual Report and AGM Notice
7th Jul 20173:45 pmRNSPortfolio Listing, May 2017
4th Jul 20173:28 pmRNSNet Asset Value, May 2017
26th Jun 20174:05 pmRNSAnnual Financial Report
26th Jun 201711:21 amRNSPortfolio Listing, April 2017
23rd Jun 201710:01 amRNSHolding(s) in Company
23rd Jun 20179:50 amRNSHolding(s) in Company
21st Jun 20174:35 pmRNSHolding(s) in Company
14th Jun 20172:00 pmRNSNet Asset Value, April 2017
12th Jun 20173:54 pmRNSHolding(s) in Company
19th May 20174:59 pmRNSCompliance with Market Abuse Regulations
10th May 201712:11 pmRNSPortfolio Listing, March 2017
5th May 20171:57 pmRNSNet Asset Value, March 2017
26th Apr 20172:11 pmRNSHolding(s) in Company
25th Apr 20174:01 pmRNSHolding(s) in Company
21st Apr 20173:19 pmRNSHolding(s) in Company
21st Apr 20171:23 pmRNSHolding(s) in Company
3rd Apr 20175:01 pmRNSPortfolio Listing, February 2017
30th Mar 20177:00 amRNSNet Asset Value, February 2017
21st Mar 20179:51 amRNSDirector/PDMR Shareholding
15th Mar 20171:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20179:19 amRNSPortfolio Listing, January 2017
27th Feb 20179:25 amRNSNet Asset Value, January 2017
1st Feb 20174:25 pmRNSPortfolio Listing, December 2016
27th Jan 20177:00 amRNSNet Asset Value(s)
23rd Dec 201612:00 pmRNSPortfolio Listing, November 2016
23rd Dec 201610:29 amRNSNet Asset Value, November 2016
20th Dec 20162:15 pmRNSPosting of Half Year Report
12th Dec 20164:55 pmRNSDividend Declaration - Correction
9th Dec 20167:05 amRNSAppointment of Broker
9th Dec 20167:00 amRNSHalf-year Report
2nd Dec 20163:47 pmRNSPortfolio Update
1st Dec 201612:35 pmRNSNet Asset Value, October 2016
4th Nov 20165:08 pmRNSProhibited Period Announcement
25th Oct 20164:07 pmRNSPortfolio Listing, September 2016
25th Oct 201611:37 amRNSDirector Declaration
25th Oct 201611:32 amRNSNet Asset Value, September 2016
4th Oct 20163:32 pmRNSPortfolio Listing, August 2016
3rd Oct 20163:57 pmRNSNet Asset Value - August 2016
21st Sep 20162:11 pmRNSDirector/PDMR Shareholding
13th Sep 201611:52 amRNSResult of AGM
25th Aug 20163:29 pmRNSPortfolio Listing, July 2016
24th Aug 20169:51 amRNSNet Asset Value(s)
28th Jul 201610:48 amRNSPortfolio Listing, June 2016
28th Jul 20167:00 amRNSNet Asset Value, June 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.